Health Sciences In The Media

Due to recent cases and one known death, several agencies are issuing a warning regarding fentanyl found in cocaine. Steven Dudley, PharmD, DABAT, director of the Arizona Poison and Drug Information Center, is quoted.

Eight local nonprofits will vie for more than $115,000 at the eighth annual "Fast Pitch Tucson" to be held March 30 at the UArizona Health Sciences Innovation Building.

The U.S. Preventive Services Task Force did not include people age 65 and older in its recommendation last year to screen adults for anxiety. The task force noted that questionnaires used to screen for anxiety may be unreliable for older adults.

For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a new multicenter study.

Local doctors are working to increase awareness and education of colon cancer and screenings throughout March as part of Colorectal Cancer Awareness Month.

According to research presented at the American Heart Association’s Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions 2023, people who reported regular, uninterrupted sleep were better at sticking to exercise and diet plans while trying to lose weight.

Alzheimer's can affect us all – but women are affected much more often than men. For Germany, this corresponds to a number of around 800,000 sufferers. Research conducted by Roberta Diaz Brinton, PhD, director of the UArizona Center for Innovation in Brain Science, is cited.

The Arizona Poison and Drug Information Center at the R. Ken Coit College of Pharmacy and the Arizona Dispensaries Association are teaming up to combat a growing number of accidental marijuana intakes, especially among children.

The UArizona Steele Children's Research Center was selected by Angel Charity for Children to receive $800,000 in funding to help children in need in Tucson.

Ivo Abraham, PhD, professor of practice in the R. Ken Coit College of Pharmacy, details how biosimilar guidelines from the World Health Organization have changed over time and whether those changes are beneficial for biosimilars.